Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.

A worker in a polyvinyl chloride factory with rapidly progressive diffuse cutaneous scleroderma was treated with the humanized monoclonal antibody (Mab) CAMPATH-1H. Treatment was followed by rapid and substantial improvement in skin score, which was maintained during followup without additional ther...

詳細記述

書誌詳細
主要な著者: Isaacs, J, Hazleman, B, Chakravarty, K, Grant, J, Hale, G, Waldmann, H
フォーマット: Journal article
言語:English
出版事項: 1996